CVs to become ‘natural’ part of the toolkit for small- and mid-market GPs – Golding

GP-led deals will be a common staple within the small- and mid-cap markets, where there is more runway for company growth, head of secondaries Richard Wilmes told Secondaries Investor on the back of the firm's over €510m raise.